Active	Status	Sponsor type	Region	Phase	Filter
8 Active 2 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Faruqi, Muhammad
UNSCARRed, NCT03737721: The Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy	Active, not recruiting	2	20	Canada	Avelumab and Radical radiotherapy	AHS Cancer Control Alberta, EMD Serono, Alberta Cancer Foundation	Squamous Cell Carcinoma of the Skin	11/22	12/24
Yip, Steven
CCTG PR21, NCT04663997: 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer	Active, not recruiting	2	200	Canada	177Lu-PSMA-617, Docetaxel	Canadian Cancer Trials Group, Prostate Cancer Canada, Novartis Pharmaceuticals	Prostate Cancer	06/25	12/25
Lee, Sangjune
No trials found